Malaria Consortium Announces New Innovation Grants for Malaria Advocacy in Africa
The Malaria Consortium is launching grants to promote and encourage new and innovative advocacy initiatives by African organisations in Africa. The innovation grants are part of Mobilising for Malaria, an advocacy programme supported by GlaxoSmithKline's African Malaria Partnership and will be awarded for a year.
Global advocacy efforts from donor countries have contributed to bringing malaria to the world's attention. Now there is a real need for advocates from malaria endemic countries to mobilise people and decision-makers and encourage policy changes to ensure additional funding and interventions reach those who need them most in their own countries.
These grants will support civil society organizations or institutions, media or community leaders and others to engage in highlighting the burden of malaria in Africa. They will support ideas and partnerships that aim to reach new audiences in creative ways and tackle difficult issues such as equity, transparency and accountability in Africa.
Audiences could include decision makers at national or regional levels, politicians, media persons, ministries, international organizations or local leaders. These grants also aim to encourage the engagement of artists to amplify advocacy messages in African countries.
The Malaria Consortium is an international non-profit organisation dedicated to improving the control of malaria, especially among the poorest and most vulnerable people in Africa. The Malaria Consortium works through a regional centre of expertise based in Uganda and offices in Ethiopia, Mozambique, Zambia, and Sudan.
More information is available at http://www.malariaconsortium.org
Contact details
For more information, please contact Delphine Valette, Malaria Consortium International Advocacy Coordinator at d.valette@malariaconsortium.org
thank you for the
By mbadythank you for the information, good day.
Malaria! Life threaten
By waris AliMalaria! Life threaten disease
Malaria, the world's most important parasitic infectious disease, is transmitted by mosquitoes which breed in fresh or occasionally brackish water. The symptoms of malaria include fever, chills, headache, muscle aches, tiredness, nausea and vomiting, diarrhoea, anaemia, and jaundice (yellow colouring of the skin and eyes). Convulsions, coma, severe anaemia and kidney failure can also occur. The severity and range of symptoms depend on the specific type of malaria. In certain types, the infection can remain inactive for up to five years and then recur. In areas with intense malaria transmission, people can develop protective immunity after repeated infections. Without prompt and effective treatment, malaria can evolve into a severe cerebral form followed by death. Malaria is among the five leading causes of death in under-5-year-old children in Africa.
WHO estimates 300-500 million cases of malaria, with over one million deaths each year.
malaria occurs mostly in tropical and subtropical countries, particularly in Africa south of the Sahara, South-East Asia, and the forest fringe zones in South America.
Therefore it is good step for providing the funding for preventation of this disease.